{
  "id": "5e48b397d14c9f295d000013",
  "type": "summary",
  "question": "Describe MAGNIMS criteria.",
  "ideal_answer": "Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) network proposed modifications to the MRI criteria to define dissemination in space (DIS) and time (DIT) for the diagnosis of multiple sclerosis in patients with clinically isolated syndrome (CIS).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28235075",
    "http://www.ncbi.nlm.nih.gov/pubmed/29856160",
    "http://www.ncbi.nlm.nih.gov/pubmed/30169254",
    "http://www.ncbi.nlm.nih.gov/pubmed/28492101",
    "http://www.ncbi.nlm.nih.gov/pubmed/28093711",
    "http://www.ncbi.nlm.nih.gov/pubmed/29275979",
    "http://www.ncbi.nlm.nih.gov/pubmed/27600111",
    "http://www.ncbi.nlm.nih.gov/pubmed/30915227"
  ],
  "snippets": [
    {
      "text": "OBJECTIVES: We compared validity of 2010 McDonald and newly proposed 2016 Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) criteria for dissemination in space (DIS) in predicting the conversion to clinically definite multiple sclerosis (CDMS) in patients with clinically isolated syndrome (CIS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28492101",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSION: 2016 MAGNIMS magnetic resonance imaging (MRI) criteria for DIS showed higher sensitivity but lower specificity than 2010 McDonald criteria in predicting conversion to CDMS in CIS patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28492101",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29275979",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "BACKGROUND: In 2016, the Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) network proposed modifications to the MRI criteria to define dissemination in space (DIS) and time (DIT) for the diagnosis of multiple sclerosis in patients with clinically isolated syndrome (CIS). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29275979",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Applicability of McDonald 2010 and Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) 2016 Magnetic Resonance Imaging Criteria for the Diagnosis of Multiple Sclerosis in Sri Lanka.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29856160",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "BACKGROUND AND PURPOSE: The magnetic resonance imaging in multiple sclerosis (MAGNIMS) group recently proposed guidelines to replace the existing dissemination-in-space criteria in McDonald 2010 magnetic resonance imaging (MRI) criteria for diagnosing multiple sclerosis. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29856160",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Performance of the 2001, 2010, and 2017 international McDonald criteria for the diagnosis of multiple sclerosis, the 2016 MRI in multiple sclerosis (MAGNIMS) criteria, and our 2011 proposed (Verhey) criteria were determined; performance was adjudicated with generalised linear models.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30169254",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " While \u2a7e1 periventricular lesion is included in the 2010 DIS criteria, earlier McDonald criteria required \u2a7e3 periventricular lesions to confirm DIS and recent Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS)-recommended DIS criteria also require \u2a7e3 lesions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27600111",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therefore, in the most recent MRI criteria for the diagnosis of MS (MAGNIMS consensus guidelines), neurophysiological confirmation of optic nerve dysfunction (slowed conduction on visual EP), support dissemination in space and, in patients without concurrent visual symptoms, dissemination in time. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28093711",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28235075",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We sought to evaluate the reliability of CL detection on DIR longitudinally at multiple subsequent time-points applying the MAGNIMs scoring criteria for CLs.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28235075",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND\n\nIn 2016, the Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) network proposed modifications to the MRI criteria to define dissemination in space (DIS) and time (DIT) for the diagnosis of multiple sclerosis in patients with clinically isolated syndrome (CIS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29275979",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Evaluation of 2016 MAGNIMS MRI criteria for dissemination in space in patients with a clinically isolated syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28492101",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "OBJECTIVES\n\nWe compared validity of 2010 McDonald and newly proposed 2016 Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) criteria for dissemination in space (DIS) in predicting the conversion to clinically definite multiple sclerosis (CDMS) in patients with clinically isolated syndrome (CIS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28492101",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND AND PURPOSE\n\nThe magnetic resonance imaging in multiple sclerosis (MAGNIMS) group recently proposed guidelines to replace the existing dissemination-in-space criteria in McDonald 2010 magnetic resonance imaging (MRI) criteria for diagnosing multiple sclerosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29856160",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We sought to evaluate the reliability of CL detection on DIR longitudinally at multiple subsequent time-points applying the MAGNIMs scoring criteria for CLs.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28235075",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In 2016 , the Magnetic Resonance Imaging in Multiple Sclerosis ( MAGNIMS ) network proposed modifications to the MRI criteria to define dissemination in space ( DIS ) and time ( DIT ) for the diagnosis of multiple sclerosis in patients with clinically isolated syndrome ( CIS",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29275979",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Evaluation of 2016 MAGNIMS MRI criteria for dissemination in space in patients with a clinically isolated syndrome",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28492101",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We compared validity of 2010 McDonald and newly proposed 2016 Magnetic Resonance Imaging in Multiple Sclerosis ( MAGNIMS ) criteria for dissemination in space ( DIS ) in predicting the conversion to clinically definite multiple sclerosis ( CDMS ) in patients with clinically isolated syndrome ( CIS",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28492101",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVES\nWe compared validity of 2010 McDonald and newly proposed 2016 Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) criteria for dissemination in space (DIS) in predicting the conversion to clinically definite multiple sclerosis (CDMS) in patients with clinically isolated syndrome (CIS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28492101",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSION\n2016 MAGNIMS magnetic resonance imaging (MRI) criteria for DIS showed higher sensitivity but lower specificity than 2010 McDonald criteria in predicting conversion to CDMS in CIS patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28492101",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND AND PURPOSE\nThe magnetic resonance imaging in multiple sclerosis (MAGNIMS) group recently proposed guidelines to replace the existing dissemination-in-space criteria in McDonald 2010 magnetic resonance imaging (MRI) criteria for diagnosing multiple sclerosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29856160",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND\nIn 2016, the Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) network proposed modifications to the MRI criteria to define dissemination in space (DIS) and time (DIT) for the diagnosis of multiple sclerosis in patients with clinically isolated syndrome (CIS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29275979",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "At 36 months, the two DIS criteria showed high sensitivity (2010 McDonald 0\u00b791 [95% CI 0\u00b785-0\u00b794] and 2016 MAGNIMS 0\u00b793 [0\u00b788-0\u00b796]), similar specificity (0\u00b733 [0\u00b725-0\u00b742] and 0\u00b732 [0\u00b724-0\u00b741]), and similar area under the curve values (AUC; 0\u00b762 [0\u00b757-0\u00b767] and 0\u00b763 [0\u00b758-0\u00b767]).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29275979",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "While \u2a7e1 periventricular lesion is included in the 2010 DIS criteria, earlier McDonald criteria required \u2a7e3 periventricular lesions to confirm DIS and recent Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS)-recommended DIS criteria also require \u2a7e3 lesions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27600111",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PURPOSE: The magnetic resonance imaging in multiple sclerosis (MAGNIMS) group recently proposed guidelines to replace the existing dissemination-in-space criteria in McDonald 2010 magnetic resonance imaging (MRI) criteria for diagnosing multiple sclerosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29856160",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We compared validity of 2010 McDonald and newly proposed 2016 Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) criteria for dissemination in space (DIS) in predicting the conversion to clinically definite multiple sclerosis (CDMS) in patients with clinically isolated syndrome (CIS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28492101",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "2016 MAGNIMS magnetic resonance imaging (MRI) criteria for DIS showed higher sensitivity but lower specificity than 2010 McDonald criteria in predicting conversion to CDMS in CIS patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28492101",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To evaluate the 2005 and 2016 MAGNIMS magnetic resonance imaging criteria for dissemination in space for multiple sclerosis, both alone and with oligoclonal bands in cerebrospinal fluid added, as predictors of a first clinical event consistent with central nervous system demyelination in children with radiologically isolated syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30915227",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "For the 2016 MAGNIMS dissemination in space criteria diagnostic indices were: sensitivity 76.5% (50.1-93.2%) versus 100% (84.6-100%); specificity 72.7% (49.8-89.3%) versus 25.6% (13.0-42.1%).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30915227",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The magnetic resonance imaging in multiple sclerosis (MAGNIMS) group recently proposed guidelines to replace the existing dissemination-in-space criteria in McDonald 2010 magnetic resonance imaging (MRI) criteria for diagnosing multiple sclerosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29856160",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In 2016, the Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) network proposed modifications to the MRI criteria to define dissemination in space (DIS) and time (DIT) for the diagnosis of multiple sclerosis in patients with clinically isolated syndrome (CIS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29275979",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}